tiprankstipranks
Avanos Medical (AVNS)
NYSE:AVNS
Holding AVNS?
Track your performance easily

Avanos Medical (AVNS) Earnings Date & Reports

164 Followers

Earnings Data

Report Date
Feb 25, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
$0.4
Last Year’s EPS
$0.36
Same Quarter Last Year
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Oct 30, 2024
|
% Change Since: -28.94%
|
Next Earnings Date:Feb 25, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were notable achievements in the Digestive Health and Game Ready portfolios, as well as progress in transformation efforts and SG&A optimization, there were significant challenges in the surgical pain portfolio and COOLIEF offering in North America. The HA portfolio also faced pricing pressures.
Company Guidance
During the Avanos Medical Q3 2024 earnings call, the guidance for the fourth quarter was discussed in detail. The company anticipates revenue in the range of $175 million to $180 million, reflecting low to mid-single-digit organic growth. The adjusted gross margin is expected to be approximately 59%, while the adjusted SG&A is projected to consume about 40% of revenue. The company forecasts adjusted diluted earnings per share to range between $0.38 and $0.43. Avanos remains focused on executing its transformation strategy, seeking consistent mid-single-digit top-line growth to support its financial objectives. The company also plans to maintain a strong balance sheet, with an anticipated net debt of approximately $20 million by year-end, supported by strategic M&A opportunities and capital allocation strategies.
Digestive Health Portfolio Growth
The Digestive Health portfolio grew almost 3% organically compared to the previous year, reaffirming the company's #1 position in long-term, short-term, and NeoMed feeding. This was supported by strong demand for ENFit conversions in North America.
Positive Financial Metrics
Generated approximately $170 million in sales from continuing operations, $0.36 of adjusted diluted earnings per share, and approximately $31 million of adjusted EBITDA from continuing operations, marking an 18% adjusted EBITDA margin.
Game Ready Portfolio Performance
The Game Ready portfolio posted its third consecutive quarter of double-digit growth compared to the prior year.
SG&A Optimization and Margin Improvement
Adjusted SG&A as a percentage of revenue improved by 180 basis points compared to the third quarter of last year and 320 basis points sequentially, primarily driven by cost savings efforts.
Transformation Progress
Achieved significant milestones in transformation efforts, including divesting respiratory health business and maintaining above-market growth in the enteral feeding business.
---

Avanos Medical (AVNS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AVNS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 20252024 (Q4)
0.40 / -
0.36
Oct 30, 20242024 (Q3)
0.35 / 0.33
0.3077.49% (+0.02)
Jul 31, 20242024 (Q2)
0.29 / 0.29
0.23125.54% (+0.06)
May 02, 20242024 (Q1)
0.21 / 0.19
0.27-29.63% (-0.08)
Feb 20, 20242023 (Q4)
0.37 / 0.36
0.6-40.00% (-0.24)
Nov 01, 20232023 (Q3)
0.28 / 0.31
0.38-19.21% (-0.07)
Aug 09, 20232023 (Q2)
0.30 / 0.23
0.41-43.66% (-0.18)
May 03, 20232023 (Q1)
0.28 / 0.27
0.263.85% (+0.01)
Feb 21, 20232022 (Q4)
0.49 / 0.60
0.4630.43% (+0.14)
Nov 02, 20222022 (Q3)
0.35 / 0.38
0.2552.00% (+0.13)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

AVNS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 30, 2024$22.63$18.58-17.90%
Jul 31, 2024$22.96$23.92+4.18%
May 02, 2024$18.79$19.71+4.90%
Feb 20, 2024$19.19$19.50+1.62%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Avanos Medical (AVNS) report earnings?
Avanos Medical (AVNS) is schdueled to report earning on Feb 25, 2025, TBA Not Confirmed.
    What is Avanos Medical (AVNS) earnings time?
    Avanos Medical (AVNS) earnings time is at Feb 25, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AVNS EPS forecast?
          AVNS EPS forecast for the fiscal quarter 2024 (Q4) is $0.4.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis